Proxy advisory firm Glass Lewis on Monday suggested that Allergan Inc shareholders join hedge fund manager William Ackman in calling for a special shareholder meeting. Valeant Pharmaceuticals Inc, with Ackman's help, offered to purchase Allergan for $51 billion but has been rebuffed. That prompted Ackman, Allergan's largest shareholder, to call for a special shareholder meeting and he has asked proxy advisory firms to weigh in.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 1.16% or $-1.92/share to $163.70. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2968980 shares of AGN exchange hands on a given day and today's volume is recorded at 2275407.
Source
